Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial.

Abstract

Spartan Biosciences.

Full Text

• DOI - Lancet (DOI)
• Swets Information Services - full-text online
• OhioLINK Electronic Journal Center - full-text online
• Elsevier Science - full-text online
• EBSCO - full-text online

Subjects

• Acute Coronary Syndrome
• Aged
• Angioplasty, Balloon, Coronary
• Aryl Hydrocarbon Hydroxylases
• Female
• Genetic Testing
• Genotype
• Heterozygote Detection
• Humans
• Individualized Medicine
• Loss of Heterozygosity
• Male
• Middle Aged
• Pharmacogenetics
• Piperazines
• Platelet Aggregation
• Platelet Aggregation Inhibitors
• Point-of-Care Systems
• Purinergic P2Y Receptor Antagonists
• Thiophenes
• Ticlopidine

Authors

• Jason D Roberts
• George A Wells
• Michel R Le May
• Marino Labinaz
• Chris Glover
• Michael Froeschl
• Alexander Dick
• Jean-Francois Marquis
• Edward O'Brien
• Sandro Goncalves
• Irena Druce
• Alexandre Stewart
• Michael H Gollob
• Derek Y F So

Publication date

2012-05-07

Journal

Journal topics

• Medicine

Language

Eng.

Copyright

Lancet

Division of Cardiology, University of Ottawa Heart Institute, Ottawa, ON, Canada.

Release reference

Lancet. 2012 May;379(9827):1705-11

Related books

• Books of Acute Coronary Syndrome
• Books of Angioplasty, Balloon, Coronary
• Books of Aryl Hydrocarbon Hydroxylases
• Books of Genetic Testing
• Books of Genotype
• Books of Heterozygote Detection
• Books of Individualized Medicine
• Books of Loss of Heterozygosity
• Books of Medicine
• Books of Pharmacogenetics
• Books of Piperazines
• Books of Platelet Aggregation
• Books of Platelet Aggregation Inhibitors
• Books of Point-of-Care Systems
• Books of Purinergic P2Y Receptor Antagonists
• Books of Thiophenes
• Books of Ticlopidine